The Sarah Cannon Research Institute / Tennessee Oncology — Nashville, Tennessee

The Sarah Cannon Research Institute / Tennessee Oncology is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

The Sarah Cannon Research Institute / Tennessee Oncology has participated in 1 clinical trials.

Therapeutic areas: Squamous Cell Non Small Cell Lung Cancer, Prostate Cancer Metastatic, Cutaneous Melanoma.

Sponsors: MacroGenics.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Sarah Cannon Research Institute / Tennessee Oncology?

The Sarah Cannon Research Institute / Tennessee Oncology has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Sarah Cannon Research Institute / Tennessee Oncology conducted?

The Sarah Cannon Research Institute / Tennessee Oncology has 1 clinical trials on record. Their work covers Squamous Cell Non Small Cell Lung Cancer, Prostate Cancer Metastatic, Cutaneous Melanoma.

Is The Sarah Cannon Research Institute / Tennessee Oncology accredited by Crixeo Health?

The Sarah Cannon Research Institute / Tennessee Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Sarah Cannon Research Institute / Tennessee Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.